Digital Credit Is Making Pharma Payments Work

Behind every prescription lies a story of procurement, payment, and distribution that often goes untold. The pharma supply chain is complex, multilayered, and under constant pressure to deliver fast and stay compliant.

Yet the one friction point that slows everything down? Payments.

The Traditional Flow (and its Flaws):

1. Retailer places an order with a distributor.
2. Distributor delivers—often on credit.
3. Retailer repays after selling stock.
4. Distributor clears dues with the manufacturer.

Sounds simple, until someone misses a payment or delays cash flow. Now imagine this repeated across 1,000+ transactions daily.

Why Digital Credit is the Missing Link:

• On-Demand Financing: Fundly.ai offers credit that moves as fast as the pharma industry needs it to.
• Smart Disbursement: Payments are automatically routed to the right stakeholders, reducing errors.
• Transparent Terms: No hidden fees or ambiguity—everything is visible, trackable, and fair.

Tech + Trust = Seamless Supply Chains

By embedding financial tools directly into the workflow, Fundly.ai ensures payments are no longer bottlenecks. Retailers order confidently. Distributors scale operations. Manufacturers ramp up production—all without waiting on aging receivables.

Case in Point:

A Tier-2 city distributor reduced receivable cycles by 40% after switching to Fundly.ai. Inventory turnover improved. So did their sleep.

Conclusion:

The future of pharma is not just about better medicines—it’s about better money movement. From prescription to payment, Fundly.ai is ensuring every step in the chain is as efficient as the end goal: healing.